Pegylated interferon α-2a triggers NK-cell functionality and specific T-cell responses in patients with chronic HBV infection without HBsAg seroconversion

Autor: Ophelie Brevot-Lutton, Noelle Pouget, Tania Dufeu-Duchesne, Caroline Aspord, Magali Bouvier-Alias, Joel Plumas, Marc Bourlière, Juliana Bruder Costa, Vincent Leroy, Inga Bertucci, Fabien Zoulim
Přispěvatelé: Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Hépato-gastroentérologie, Assistance Publique - Hôpitaux de Marseille (APHM), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de biologie et chimie des protéines [Lyon] (IBCP), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), ANRS, Agence Nationale de Recherches sur le Sida et les Hepatites Virales, Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
T-Cell Antigen Receptor Specificity
Lymphocyte Activation
Polyethylene Glycols
Interleukin 21
0302 clinical medicine
Animal Cells
T-Lymphocyte Subsets
phase 3 clinical trial (topic)
T lymphocyte
Public and Occupational Health
IL-2 receptor
CD8+ T lymphocyte
lcsh:Science
Immune Response
Innate Immune System
clinical article
Innate lymphoid cell
Acquired immune system
3. Good health
cell activation
Killer Cells
Natural

lymphocyte function
Interleukin 12
Cytokines
030211 gastroenterology & hepatology
Cellular Types
phenotype
Immune Cells
T cell
Immunology
Cytotoxic T cells
Article
peginterferon alpha2a
03 medical and health sciences
Hepatitis B
Chronic

Humans
chronic hepatitis B
T Helper Cells
human
seroconversion
Aged
CD4+ T lymphocyte
Blood Cells
Hepatitis B Surface Antigens
human cell
lcsh:R
Biology and Life Sciences
Dendritic Cells
Molecular Development
hepatitis B surface antigen
030104 developmental biology
DNA
Viral

lcsh:Q
Preventive Medicine
Biomarkers
Developmental Biology
0301 basic medicine
Physiology
T-Lymphocytes
lcsh:Medicine
NK cells
White Blood Cells
Liver Function Tests
Immune Physiology
Medicine and Health Sciences
randomized controlled trial (topic)
innate immunity
Staining
Multidisciplinary
T Cells
Cell Staining
adaptive immunity
Middle Aged
Viral Load
Vaccination and Immunization
Recombinant Proteins
Treatment Outcome
medicine.anatomical_structure
multicenter study (topic)
Female
Research Article
Adult
dendritic cell
[SDV.CAN]Life Sciences [q-bio]/Cancer
cellular immunity
Biology
Research and Analysis Methods
Natural killer cell
Immune system
Antiviral Therapy
evolution
medicine
drug mechanism
controlled study
nucleoside analog
Interferon-alpha
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Cell Biology
natural killer cell
Specimen Preparation and Treatment
Immune System
Zdroj: PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
PLoS ONE, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
PLoS ONE, Vol 11, Iss 6, p e0158297 (2016)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0158297⟩
Popis: International audience; Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune responses are critical for virus control, we investigated the effects of Peg-IFN-α on both innate and adaptive immunity, and related it to the clinical evolution. The phenotypic and functional features of the dendritic cells (DCs), natural killer (NK) cells and HBV-specific CD4/CD8 T cells were analyzed in HBeAg-negative CHB patients treated for 48-weeks with NA alone or together with Peg-IFN-α, before, during and up to 2-years after therapy. Peg-IFN-α induced an early activation of DCs, a potent expansion of the CD56bright NK subset, and enhanced the activation and functionality of the CD56dim NK subset. Peg-IFN-α triggered an increase in the frequencies of Th1- and Th17-oriented HBV-specific CD4/CD8 T cells. Peg-IFN-α reversed the unresponsiveness of patients to a specific stimulation. Most of the parameters returned to baseline after the stop of Peg-IFN-α therapy. Peg-IFN-α impacts both innate and adaptive immunity, overcoming dysfunctional immune responses in CHB patients. These modulations were not associated with seroconversion, which questioned the benefit of the add-on Peg-IFN-α treatment. © 2016 Bruder Costa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Databáze: OpenAIRE